Tomer Babu

University of Texas at Austin

United States

Research Interests

Explore related searches

Professors in United States Professors in Drug Delivery Drug Delivery professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Collaborators (9)

Dan Gibson

ISRAEL

View details

Alexander Kastner

Universität Wien

AUSTRIA

View details

Gunda Koellensperger

Professor

AUSTRIA

View details

Norman Metanis

ISRAEL

View details

Petra Heffeter

Full professor

Medical University of Vienna

AUSTRIA

View details

Viktor Brabec

Professor

Palacký University, Olomouc

CZECH REPUBLIC

View details

Ingo Ott

Professor

Technische Universität Braunschweig

GERMANY

View details

Valentina Gandin

University of Padova

ITALY

View details

Giorgia Pastorin

National University of Singapore (NUS)

SINGAPORE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tomer Babu

Research Interests

Explore related searches

Contact this professor

Articles (10)

Multitargeting Pt(IV) Derivatives of Cisplatin or Oxaliplatin Inhibit Tumor Growth in Mice without Inducing Neuropathic Pain

Three Is Better than One: A Multimetal Complex that Triggers Immunogenic Cell Death

Three Is Better than One: A Multimetal Complex that Triggers Immunogenic Cell Death

Cisplatin-eugenol Pt(IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacy

Stepwise optimization of tumor-targeted dual-action platinum(iv)-gemcitabine prodrugs

Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death

Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death

Oral Anticancer Heterobimetallic PtIV−AuI Complexes Show High In Vivo Activity and Low Toxicity

Oral Anticancer Heterobimetallic PtIV−AuI Complexes Show High In Vivo Activity and Low Toxicity

Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?

Collaborators (9)

Dan Gibson

Alexander Kastner

Gunda Koellensperger

Norman Metanis

Petra Heffeter

Viktor Brabec

Ingo Ott

Valentina Gandin

Giorgia Pastorin

Make your next move.